Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure.
Michele CorrealePietro MazzeoMichele MagnesaMartino FortunatoLucia TricaricoAlessandra LeopizziAdriana MallardiRaffaele MennellaSalvatore TucciNatale Daniele BrunettiPublished in: Clinical physiology and functional imaging (2021)
In a real-world scenario, 6-month therapy with S/V was associated with an improved RV function in HFrEF. RV function improvement may be predicted by assessing baseline RV S' and right atrial volume values.